EUVIMEDEUVIMED entdecken
FallberichtOpen Access · CC BY-NC-ND 4.0

Pulmonary thrombotic pulmonary hypertension managed using antithrombotic and pulmonary vasodilator treatment

Rina Horikawa, Ryohei Suzuki iD, Yunosuke Yuchi iD, Shuji Satomi, Takahiro Saito, Takahiro Teshima iD, Hirotaka Matsumoto

Journal of Veterinary Internal Medicine · 2024

DOI: 10.1111/jvim.17089 ↗

Kurz gefasst

Fallbericht in der Zeitschrift Journal of Veterinary Internal Medicine, 2024. Verfasst von Rina Horikawa und 6 weiteren Autor:innen. Beteiligte Einrichtung: Laboratory of Veterinary Internal Medicine, School of Veterinary Science, Faculty of Veterinary Medicine, Nippon Veterinary and Life Science Universi…. Hauptthemen laut MEDLINE: Hypertension, Pulmonary, Fibrinolytic Agents, Vasodilator Agents. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 22 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Japan Society for the Promotion of Science.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

An 8-year-old Leonberger receiving immunosuppressive treatment with clinical signs of acute dyspnea, cyanosis, and difficulty standing was referred to our institution (Day 1). Treatment including oxygen, clopidogrel, and low-molecular-weight heparin was initiated for suspected pulmonary thrombosis. However, exertional dyspnea persisted until Day 10, and increased tricuspid regurgitation velocity, pulmonary vascular resistance, and McConnell's signs also were observed. Thus, beraprost sodium was administered PO on Day 11 to treat suspected pulmonary hypertension. On Day 13, contrast-enhanced computed tomography identified extensive contrast defects in the pulmonary arteries, and IV monteplase was administered on Days 14 and 18, with marked improvement in respiratory status and exertional dyspnea on Day 20. Right ventricular function and McConnell signs also improved, and tricuspid regurgitation velocity and pulmonary vascular resistance decreased. On Day 250, echocardiography indicated further improvement in pulmonary hypertension pathophysiology. The patient was still progressing well with antithrombotic and pulmonary vasodilator treatment 400 days later.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Hypertension, PulmonaryFibrinolytic AgentsVasodilator AgentsAnimalsDogsDog DiseasesMaleEpoprostenolThrombosis

Stichwörter der Autor:innen

beraprost sodiumcontrast‐enhanced computed tomographymonteplasemyocardial strainpulmonary vascular resistancespeckle tracking echocardiography

Substanzen

Fibrinolytic AgentsVasodilator AgentsberaprostEpoprostenol

Autor:innen und Institutionen

  • Laboratory of Veterinary Internal Medicine, School of Veterinary Science, Faculty of Veterinary Medicine, Nippon Veterinary and Life Science University, Tokyo, Japan.
  • Takahashi Animal Hospital, Saitama, Japan.

ORCID-Profile: Ryohei Suzuki, Yunosuke Yuchi, Takahiro Teshima

Förderung

  • Japan Society for the Promotion of Science

Zitieren

APA

Horikawa, R., Suzuki, R., Yuchi, Y., Satomi, S., Saito, T., Teshima, T., & Matsumoto, H. (2024). Pulmonary thrombotic pulmonary hypertension managed using antithrombotic and pulmonary vasodilator treatment. Journal of Veterinary Internal Medicine. https://doi.org/10.1111/jvim.17089

Vancouver

Horikawa R, Suzuki R, Yuchi Y, Satomi S, Saito T, Teshima T, et al. Pulmonary thrombotic pulmonary hypertension managed using antithrombotic and pulmonary vasodilator treatment. Journal of Veterinary Internal Medicine. 2024. doi:10.1111/jvim.17089

BibTeX
@article{Horikawa2024,
  author = {Horikawa, Rina and Suzuki, Ryohei and Yuchi, Yunosuke and Satomi, Shuji and Saito, Takahiro and Teshima, Takahiro and Matsumoto, Hirotaka},
  title = {Pulmonary thrombotic pulmonary hypertension managed using antithrombotic and pulmonary vasodilator treatment},
  journal = {Journal of Veterinary Internal Medicine},
  year = {2024},
  doi = {10.1111/jvim.17089}
}
Kostenlos starten →